Sernova Biotherapeutics Inc

C$0.11As of Sun 8 Nov 2026, 12:00 UTC
TSX:SVAHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (9.22%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM (26.67%)
Mkt cap C$41.54M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.116
5.17%
(67.23%)
Hold 8|8|9|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
13.93%
11.89%
16.34%
24.72%
Revenue$M
2.185
2.157
2.119
2.087
8.40%
8.68%
1.60%
(3.23%)
Peers (US$29.40M)
Cap (US$)
PE
29.46M
—
Capital
TTM
5Y
10Y
Leveragex
1.101
(0.021)
(0.019)
EBIT/Intx
0.965
0.144
0.137
Own earn%
(32.92)
(116.14)
(97.75)
Sh yield%
47.22
37.98
37.85
Owners
Insiders/Inst%
5.67
81.18
Short interest%
4.88
SBC / revenue%
5.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
18–26
$1 testx
0.3
Incr. ROIC%
3